Clinical Trial Update: A Study of Talazoparib in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of talazoparib in patients with advanced solid tumors has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2018-12-17